1.Technique for the Cultivation of Ural Licorice(Glycyrrhiza uralensis)in Saline-alkali Soil
Maozhong TIANG ; Fengling LI ; Ziliang SUN
Chinese Traditional and Herbal Drugs 1994;0(03):-
Biogenic characteristiccs for the growth of Glycyrrhiza uralensis in saline-alkali soil was reported. Typesof saline- alkali soil sultable for the growth of G. uralensis,and technique of cultivation management and processing of G. uralensis in saline-alkali soil were discussed. Thus it provides a basis for the growth of G. uralensis in saline-alkali soil.
2.Survey on the intake of dietary nutrients for 132 aduit patients with acute and chronic leukemia
Ziliang XU ; Yuntang WU ; Zhong SUN ; Rui LI ; Hongqiang LI ; Yumei QI ; Jichang SONG ; Jianxiang WANG ; Mingzhe HAN ; Fengkui ZHANG ; Lugui QIU ; Xiaofan ZHU ; Zhijian XIAO ; Renchi YANG ; Yizhou ZHENG ; Sizhou FENG ; Zhongchao HAN
Journal of Leukemia & Lymphoma 2009;18(1):29-31,34
Objective To study the dietary nourishment of adult patients with leukemia and compare acute leukemic patients with chronic leukemic patients. Methods Adopting dietary review of 24 hours and seven consecutive days of dietary records method to obtain the food category and quantity of 122 patients with acute leukemia and 10 patients with chronic leukemia. Using statistic software SPSS11.0 to calculate the patients'intake of various kinds of nutfiments. and the difiences between acute and chronic leukemic patients were analyzed. Results The rate of most ontrients of patients'intake reaches RNI/AI is lower,especially vitamin A,vitamin C and caleium.There's a tendency that intake diet,energy and nourishments of acute leukemic patients is lower than that of those chronic leukemic patients. Conclusion There is a tendency of unbalanced dietary intakes in leukemic patients.including the low intakes.There is the tendency that nutritional status of acute leukemic patients iS poorer than that of chronic leukemic patients.
3.Effects of pretreatment with nicorandil on PDCD4/NF-κB/TNF-α pathway in coronary microembolization
Qiang SU ; Lang LI ; Yuhan SUN ; Ziliang YE ; Xuefei YANG ; Binghui KONG
Chinese Journal of Emergency Medicine 2018;27(10):1083-1088
Objective To investigate the role of nicorandil pretreatment on protecting myocardium after coronary microembolization (CME) and on the PDCD4/NF-κB/TNF-α signaling pathway in miniature pigs. Methods Fifteen Bama miniature pigs were randomly(random number) divided into the sham operation group (sham group), microembolization group (CME group) and CME plus nicorandil group, with 5 pigs in each group. The CME model was constructed by injecting polyethylene microspheres via microcatheter into the left anterior descending artery, and pigs in the sham group were injected with the same amount of saline. Pigs in the CME plus nicorandil group were injected intravenously with nicorandil (150 μg/kg) via ear vein 30 min before CME. Cardiac function indexes were measured using cardiac ultrasonography. The expression of PDCD4 and TNF-α mRNA in myocardium were detected by fluorescence quantitative PCR, and the protein expression of PDCD4 and TNF-α in myocardium were detected by Western blotting. NF-κB activation was evaluated by electrophoretic mobility shift assay. Results (1) Cardiac function was significantly lower and the level of serum cTnI was significantly higher in the CME group compared with the sham group. CME reduced myocardial systolic dysfunction and left ventricular dilatation. The CME plus nicorandil group showed improved CME-induced cardiac function and reduced serum cTnI level when compared with the CME Group (P < 0.05). (2) Compared with the CME group, the CME plus nicorandil group showed lower PDCD4 and TNF-α expression and NF-κB activity as well as improved cardiac function (P < 0.05). Conclusions The pretreatment of nicorandil effectively reduced the myocardial damage caused by CME, mainly through inhibiting the PDCD4/NF-κB/TNF-α pathway in cardiomyocytes.
4.Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.
Sisi KANG ; Mei YANG ; Zhongsi HONG ; Liping ZHANG ; Zhaoxia HUANG ; Xiaoxue CHEN ; Suhua HE ; Ziliang ZHOU ; Zhechong ZHOU ; Qiuyue CHEN ; Yan YAN ; Changsheng ZHANG ; Hong SHAN ; Shoudeng CHEN
Acta Pharmaceutica Sinica B 2020;10(7):1228-1238
The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the -sheet core. Complemented by binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.